Oncolytics Biotech
ONCY
#9296
Rank
A$0.14 B
Marketcap
A$1.39
Share price
3.25%
Change (1 day)
69.45%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -A$38.66 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$36.92 Million a decrease over its 2023 earnings that were of -A$36.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.66 Million4.7%
2024 -A$36.92 Million1.01%
2023 -A$36.56 Million23.39%
2022 -A$29.63 Million-1.98%
2021 -A$30.22 Million9.1%
2020 -A$27.7 Million22.64%
2019 -A$22.59 Million22.78%
2018 -A$18.4 Million4.1%
2017 -A$17.67 Million4.87%
2016 -A$16.85 Million8.75%
2015 -A$15.5 Million-37.06%
2014 -A$24.62 Million-26.2%
2013 -A$33.36 Million-37.39%
2012 -A$53.28 Million28.8%
2011 -A$41.37 Million46.02%
2010 -A$28.33 Million35.64%
2009 -A$20.89 Million-14.2%
2008 -A$24.34 Million-0.52%
2007 -A$24.47 Million24.6%
2006 -A$19.64 Million45.34%
2005 -A$13.52 Million-11.8%
2004 -A$15.32 Million115.36%
2003 -A$7.12 Million13.86%
2002 -A$6.25 Million-5.45%
2001 -A$6.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$37.33 B-103,533.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.53 B-37,596.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.11 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.96 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.12 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$42.14 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA